Document Detail

Reoperative valve surgery in the elderly: predictors of risk and long-term survival.
MedLine Citation:
PMID:  20868814     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Elderly patients requiring reoperative cardiac surgery for valve disease are considered high risk for immediate outcomes, but little is known about their long-term survival. It is often conjectured that medical therapy provides equivalent late survival in this population, which may dissuade both patient and surgeon from considering reoperation. We analyzed a cohort of such patients undergoing reoperative valve surgery to determine their long-term survival. METHODS: From 1992 through 2007, 363 patients aged 75 years or more underwent reoperative isolated valve surgery; 211 (58%) had aortic valve replacement and 152 (42%) had mitral valve surgery. Mean age was 80.5 years. Hospital outcomes were prospectively recorded. Survival from all-cause death was determined from the Social Security Death Index. RESULTS: Hospital mortality was 13.8% (12.8% for aortic and 15.1% for mitral valve operations; p = 0.52). Multivariable predictors of hospital death were New York Heart Association functional class III or IV heart failure (odds ratio = 3.19, p = 0.012), dialysis (odds ratio = 15.63, p = 0.003), and more than one reoperation (odds ratio = 2.59, p = 0.058). At 5 years, overall survival was 62% ± 3% for all patients (66% ± 4% for aortic and 56% ± 4% for mitral valve patients). For aortic valve patients aged 80 years or more, 5-year survival was 60% ± 0.6%. Life expectancy table analysis predicted a 5-year survival of 57% for an age-matched and sex-matched comparison group. CONCLUSIONS: Reoperative surgery for elderly patients with isolated aortic or mitral valve pathology is associated with excellent long-term survival, particularly when treating aortic valve disease. While in-hospital mortality is higher among the elderly than among younger patients, specific predictors of poor outcome can be identified preoperatively to risk stratify these patients.
Leora B Balsam; Eugene A Grossi; David G Greenhouse; Patricia Ursomanno; Abelardo Deanda; Greg H Ribakove; Alfred T Culliford; Aubrey C Galloway
Related Documents :
6721034 - The st. jude experience.
18835184 - Logistic risk model predicting postoperative respiratory failure in patients undergoing...
2023444 - Valve-related complications with the hancock i porcine bioprosthesis. a twelve- to four...
12911204 - Comparison of early postoperative quality of life in minimally invasive versus conventi...
7727834 - Photopheresis in the red man or pre-sézary syndrome.
8353584 - Clinical safety and cost of heparin titration using bedside activated clotting time.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  90     ISSN:  1552-6259     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-27     Completed Date:  2010-10-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1195-200; discussion 1201     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Department of Cardiothoracic Surgery, New York University School of Medicine, New York, New York 10028, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Aortic Valve / surgery*
Heart Valve Diseases / surgery*
Heart Valve Prosthesis Implantation / mortality*
Mitral Valve / surgery*
Risk Assessment
Risk Factors
Survival Analysis
Time Factors
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Invited commentary.
Next Document:  Factors affecting survival after mitral valve replacement in patients with prosthesis-patient mismat...